» Articles » PMID: 27287966

Maternal Infection During Pregnancy and Risk of Autism Spectrum Disorders: A Systematic Review and Meta-analysis

Overview
Publisher Elsevier
Date 2016 Jun 12
PMID 27287966
Citations 179
Authors
Affiliations
Soon will be listed here.
Abstract

Conflicting evidence exists with regard to the relationship between maternal infection during pregnancy and the risk of autism spectrum disorder (ASD) in offspring. The aim of this meta-analysis was to systematically assess this relationship. To identify relevant studies, we conducted systematic searches in PubMed and Embase of scientific articles published through March 2016. Random-effects models were adopted to estimate overall relative risk. A total of 15 studies (2 cohort and 13 case-control studies) involving more than 40,000 ASD cases were included in our meta-analysis. Our results showed that maternal infection during pregnancy was associated with an increased risk of ASD in offspring (OR=1.13, 95% confidence interval (CI): 1.03-1.23), particularly among those requiring hospitalization (OR=1.30, 95% CI: 1.14-1.50). Subgroup analyses suggested that risk may be modulated by the type of infectious agent, time of infectious exposure, and site of infection. These findings indicate that maternal infection during pregnancy increases the risk of ASD in offspring. Possible mechanisms may include direct effects of pathogens and, more indirectly, the effects of inflammatory responses on the developing brain.

Citing Articles

Activation of endogenous retroviruses characterizes the maternal-fetal interface in the BTBR mouse model of autism spectrum disorder.

Cipriani C, Camaioni A, Tartaglione A, Giudice M, Conti A, Petrone V Sci Rep. 2025; 15(1):8271.

PMID: 40065061 PMC: 11894120. DOI: 10.1038/s41598-025-91541-8.


Understanding the potential impact of trimester-specific maternal immune activation due to SARS-CoV-2 on early human neurodevelopment and the role of cytokine balance.

Diaz-Pons A, Castano-Castano S, Ortiz-Garcia de la Foz V, Yorca-Ruiz A, Martinez-Asensi C, Munarriz-Cuezva E Brain Behav Immun Health. 2025; 44:100956.

PMID: 39990281 PMC: 11846590. DOI: 10.1016/j.bbih.2025.100956.


Identification of Bacterial Lipopolysaccharide-Associated Genes and Molecular Subtypes in Autism Spectrum Disorder.

He Y, He Y, Cheng B Pharmgenomics Pers Med. 2025; 18():1-18.

PMID: 39850061 PMC: 11750731. DOI: 10.2147/PGPM.S494126.


Exogenous ketone bodies and the ketogenic diet as a treatment option for neurodevelopmental disorders.

Omori N, Malys M, Woo G, Mansor L Front Nutr. 2025; 11:1485280.

PMID: 39749357 PMC: 11693454. DOI: 10.3389/fnut.2024.1485280.


Biomarkers for autism spectrum disorder: a short review.

de Sena Barbosa M, de Souza R, Goncalves Cherain L, Santos Ferreira L, Santos Affi Peixoto M, Lemos Passos M Ann Med Surg (Lond). 2024; 86(12):7227-7231.

PMID: 39649921 PMC: 11623892. DOI: 10.1097/MS9.0000000000002689.